|
Mammostrat
as a tool to stratify patients at risk of recurrence during endocrine
therapy. Poster at San Antonio Breast Cancer
Symposium (SABCS) 2008
Chemosensitivity
and stratification by a five monoclonal antibody immunohistochemistry
test in the NSABP B14 and B20 trials. Clin Cancer
Res 2008 Oct 15; 14(20): 6602-9
Prognosis
and chemosensitivity using a five monoclonal antibody IHC test in node
negative, tamoxifen-treated, ER+ breast cancer - NSABP B14 and B20
trials. Poster at the American
Society of Clinical Oncology (ASCO)
2007 Breast Cancer Symposium
Chemosensitivity and stratification by a five
monoclonal antibody IHC test in the NSABP B20 trial. Poster
at American Society of Clinical Oncology (ASCO)
2007
A Five Antibody Prognostic IHC Test
Identifies Estrogen Receptor Positive Patients Classified as Luminal B
at High Risk for Tumor Progression. Poster at the
American Association for Cancer Research (AACR) Annual Meeting 2007
Validation of a
prognostic algorithm based upon a five monoclonal antibody
immunohistochemistry test in Tamoxifen- treated, node negative breast
cancer: NSABP B14 and B20 studies. Poster at San
Antonio Breast Cancer Symposium (SABCS) 2006
Novel prognostic immunohistochemical biomarker
panel for estrogen receptor-positive breast cancer. Journal
of Clinical Oncology, vol 24, No 19 (July 1) 2006: 3039-3047
Validation of a five reagent
immunohistochemistry assay for prognostication of estrogen-receptor
expressing breast cancer. Poster at American
Society of Clinical Oncology (ASCO) 2006
A novel prognostic immunohistochemical
biomarker panel for estrogen receptor expressing breast cancer.
San Antonio Breast Cancer Symposium (SABCS)
Poster 2005
Translating
gene expression patterns into IHC diagnostics for breast
cancer: novel IHC reagents predict recurrence in a retrospective cohort
at the Comprehensive Cancer Institute of Huntsville.
San Antonio
Breast Cancer Symposium (SABCS) Poster 2004
^top
TLE3
as a candidate biomarker of response to taxane therapy.
Breast Cancer Research 2009, 11:R17
TLE3 as a biomarker for taxane sensitivity in
breast cancer. Poster at American
Society of Clinical Oncology (ASCO) 2008
^top
|
|
Breast: Classification by Antibodies |
|
| |
|
|
|
|
Characterization of a novel anti-fatty acid
synthase (FASN) antiserum in breast tissue. Mod
Pathol 2008 Dec; 21(12):1413-20.
Tools to study the function of the
Ras-related, estrogen-regulated growth inhibitor in breast cancer.
Methods Enzymol. 2008;439: 53-72
Translation of breast cancer gene expression
profiles into an immunohistochemistry-based classifier. Poster
at the American Association for Cancer Research (AACR) Annual Meeting
2007.
Translation of gene
expression patterns into
immunohistochemistry biomarkers. Poster at
American
Association for Cancer Research (AACR) 2006
Basal cytokeratins and
their relationship to the cellular origin and functional classification
of breast cancer. Breast Cancer Research 2005,
7:143-148
Expression of
cytokeratins 17 and 5 identifies
a group of breast carcinomas with poor clinical outcome. Am
J Pathol. 161(6):1991-6 (2002)
Reclassifying cancer,
guided by genomics.
Cover Story CAP Today (College of American Pathologists) Jan. 2001
^top
A
novel five-antibody immunohistochemical test for subclassification of
lung carcinoma.
Mod Pathol. 2009 May 8
A
five antibody IHC
test for histotype
subclassification of non-small cell lung carcinoma. Poster
at ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer, Oct
2008
^top
Discovery
and
validation of novel biomarkers
for prediction of recurrence and treatment response. Poster
at International Association for the Study of Lung Cancer World
Conference on Lung Cancer 2006
From gene expression patterns to IHC
diagnostics: Discovery and validation of novel biomarkers for
prediction of recurrence in non-small cell carcinoma of the lung
(NSCLC). Oral Presentation at American Society of
Clinical Oncologists (ASCO) 2005
^top
Utility
of immunohistochemistry tissue array
in the prediction of epithelial ovarian carcinoma response to therapy.
American Society of Clinical Oncologists (ASCO)
Poster 2005
Gene expression patterns
in ovarian carcinomas. Mol Biol Cell.
(11):4376-86. (2003)
^top
A
Differentiation based immunohistochemical
classifier that is prognostic for head and neck tumor patients.
Poster at 2007 United States and Canadian
Academy of Pathology (USCAP) Annual Meeting
^top
Overexpression of NDRG1 is an indicator of poor
prognosis in hepatocellular carcinoma. Modern
Pathology (2007) 20, 76-83
^top
A
novel monoclonal antibody against DOG1 is
a sensitive and specific marker for gastrointestinal stromal tumors.
Am J Surg Pathol. 2008 Feb; 32(2): 210-8.
The
Novel Marker, DOG1 , Is Expressed Ubiquitously
in Gastrointestinal Stromal Tumors Irrespective of KIT
or PDGFRA Mutation Status. American
Journal of Pathology, Vol. 165, No. 1, July 2004
^top
Gene expression patterns
within cell lines are predictive of chemosensitivity. BMC
Genomics 2008 Feb 8; 9:74.
Gene expression patterns within cell lines are
predictive of chemosensitivity. American
Association for Cancer Research (AACR) Poster 2006
Microarrays and molecular markers for tumor
classification.
Genome Biology 2002;3(5): 3-6.
A comparison of gene expression signatures from
breast tumors and breast tissue derived cell lines.
Dis Markers. 2001;17(2): 99-109.
Towards a novel classification of human
malignancies based on gene expression patterns.
J Pathol. 2001 Sep;195(1): 41-52.
Rerg is a novel ras-related, estrogen-regulated
and growth-inhibitory gene in breast cancer.
J Biol Chem 2001 Nov 9;276(45): 42259-67.
Systematic variation in gene expression
patterns in human cancer cell lines.
Nat Genet. 2000 Mar;24(3): 227-35.
A gene expression database for the molecular
pharmacology of cancer.
Nat Genet 2000 Mar;24(3):236-44
Distinctive gene expression patterns in human
mammary epithelial cells and breast cancers.
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16): 9212-7.
^top
A
pilot project for generation of rabbit
monoclonal antibodies and an immunohistochemistry database exploring
the proteome. Poster at Human Protein Organization
(HUPO) Congress 2006
Follicular
Dendritic Cell Immunohistochemical Markers in Angioimmunoblastic T-Cell
Lymphoma Appl Immunohistochem Mol Morphol
2005;13:297-303
^top
|
